IDEAS home Printed from https://ideas.repec.org/f/pma2240.html
   My authors  Follow this author

Sophie Massin

Personal Details

First Name:Sophie
Middle Name:
Last Name:Massin
Suffix:
RePEc Short-ID:pma2240
[This author has chosen not to make the email address public]
https://sites.google.com/site/somassin/english

Affiliation

Lille Économie et Management (LEM)

Lille, France
http://lem.univ-lille.fr/
RePEc:edi:laborfr (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. François Facchini & Sophie Massin & Kevin Brookes, 2024. "The relationship between institutional quality, trust and private savings," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-04379761, HAL.
  2. Maxence Miéra & Sophie Massin & Vincent Eroukmanoff, 2023. "The social value of gambling: surplus estimates by gambling types for France," Post-Print hal-03972103, HAL.
  3. Maxence Miéra & Sophie Massin, 2022. "L’enjeu de l’emploi dans la régulation des jeux de hasard et d’argent en France : une analyse entrée-sortie," Post-Print hal-03972069, HAL.
  4. Davide Fortin & Vincent Di Beo & Sophie Massin & Yann Bisiou & Patrizia Carrieri & Tangui Barré, 2022. "A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use," Post-Print hal-03702711, HAL.
  5. Yves Arrighi & David Crainich & Véronique Flambard & Sophie Massin, 2022. "Personalized information and willingness to pay for non-financial risk prevention : an experiment," Post-Print hal-03700914, HAL.
  6. Sophie Massin, 2020. "La notion de jeu en économie," Post-Print hal-02948684, HAL.
  7. Sophie Massin, 2020. "Un portrait du secteur des jeux de hasard et d’argent en France," Post-Print hal-02506153, HAL.
  8. Fortin Davide & Sophie Massin, 2020. "Medical cannabis: thinking out of the box of the healthcare system," Post-Print hal-03131289, HAL.
  9. Sophie Massin & Maxence Miéra, 2020. "Measuring consumer surplus in the case of addiction: A re-examination of the rational benchmark algebra," Post-Print hal-03131254, HAL.
  10. Christian Ben Lakhdar & Antoine Deplancke & Fabrice Le Lec & Sophie Massin & Anthony Piermatteo & Nicolas Vaillant, 2020. "Protocol for creating new warnings on cigarette packs and evaluating their efficacy in a randomised experimental setting," Post-Print hal-02947325, HAL.
  11. Sophie Massin, 2019. "L’utilisation de ressources numériques en début de premier cycle universitaire : profils individuels et déterminants liés aux ressources," Post-Print hal-02499091, HAL.
  12. Sophie Massin & Antoine Nebout & Bruno Ventelou, 2017. "Predicting medical practices using various risk attitude measures," Post-Print hal-01744600, HAL.
  13. Sophie Massin, 2016. "Apports de l’évaluation socio-économique des conséquences des jeux de hasard et d’argent à la régulation du secteur," Post-Print hal-01744482, HAL.
  14. Sophie Massin, 2015. "Coûts-bénéfices des addictions sans substance," Post-Print hal-01241454, HAL.
  15. Jean-Michel Costes & Sophie Massin & Jeanne Etiemble, 2015. "L’évaluation de l’impact socio-économique des jeux d’argent et de hasard," Post-Print hal-01241493, HAL.
  16. Sophie Massin & Bruno Ventelou & Antoine Nebout-Javal & Pierre Verger & Céline Pulcini, 2015. "Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination," Post-Print hal-01241634, HAL.
  17. Stéphane Munck & Sophie Massin & Philippe Hofliger & David Darmon, 2015. "Déterminants du projet d'installation en ambulatoire des internes de médecine générale," Post-Print hal-01241646, HAL.
  18. Sophie Massin, 2014. "L'impact socio-économique des jeux de hasard et d'argent," Post-Print hal-01241415, HAL.
  19. Jean-Michel Costes & Sophie Massin & Jeanne Etiemble, 2014. "Première évaluation de l'impact socio-économique des jeux d'argent et de hasard en France," Post-Print hal-01241482, HAL.
  20. Sophie Massin & Alain Paraponaris & Marion Bernhard & Pierre Verger & Marie Cavillon & Fanny Mikol & Bruno Ventelou, 2014. "Les médecins généralistes face au paiement à la performance et à la coopération avec les infirmiers," Post-Print hal-01241473, HAL.
  21. Sophie Massin, 2013. "L'économie du tabac," Post-Print hal-01241424, HAL.
  22. Sophie Massin, 2013. "Approches économiques positives et normatives de la législation sur les drogues," Post-Print hal-01241602, HAL.
  23. Sophie Massin, 2012. "Panorama des questionnements économiques liés aux addictions," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-01241571, HAL.
  24. Sophie Massin, 2012. "Is harm reduction profitable? An analytical framework for corporate social responsibility based on an epidemic model of addictive consumption," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) inserm-00835345, HAL.
  25. Sophie Massin, 2011. "La notion d'addiction en économie : la théorie du choix rationnel à l'épreuve," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00671266, HAL.
  26. Sophie Massin, 2010. "L'éthique dans l'industrie du jeu : quels enjeux et quelle crédibilité ?," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00628426, HAL.
  27. Sophie Massin, 2009. "Firm behavior in a legal market with addiction: implications from a demand with social interactions [Le comportement des producteurs de biens addictifs légaux : implications d'une demande avec inte," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-00375546, HAL.
  28. Sophie Massin, 2009. "Le comportement des producteurs de biens addictifs légaux : implications d'une demande avec interactions sociales," Documents de travail du Centre d'Economie de la Sorbonne 09018, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
  29. Sophie Massin, 2008. "Coût social," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00628421, HAL.
  30. Sophie Massin, 2008. "The notion of addiction in economics and its challenge to the theory of rational choice [La notion d'addiction en économie : la théorie du choix rationnel à l'épreuve]," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-00331284, HAL.
  31. Sophie Massin, 2006. "La dépénalisation du cannabis : analyse économique," Post-Print hal-01241401, HAL.

Articles

  1. Maxence Miéra & Sophie Massin & Vincent Eroukmanoff, 2023. "The social value of gambling: surplus estimates by gambling types for France," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(9), pages 1531-1543, December.
  2. Sophie Massin & Maxence Miéra, 2022. "L’enjeu de l’emploi dans la régulation des jeux de hasard et d’argent en France : une analyse entrée-sortie," Revue d'économie politique, Dalloz, vol. 132(3), pages 491-514.
  3. Yves Arrighi & David Crainich & Véronique Flambard & Sophie Massin, 2022. "Personalized information and willingness to pay for non-financial risk prevention: An experiment," Journal of Risk and Uncertainty, Springer, vol. 65(1), pages 57-82, August.
  4. Sophie Massin & Maxence Miéra, 2020. "Measuring consumer surplus in the case of addiction: A re-examination of the rational benchmark algebra," Economics Bulletin, AccessEcon, vol. 40(4), pages 3171-3181.
  5. Sophie Massin & Antoine Nebout & Bruno Ventelou, 2018. "Predicting medical practices using various risk attitude measures," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(6), pages 843-860, July.
  6. Massin, Sophie, 2012. "Is harm reduction profitable? An analytical framework for corporate social responsibility based on an epidemic model of addictive consumption," Social Science & Medicine, Elsevier, vol. 74(12), pages 1856-1863.
  7. Sophie Massin, 2011. "La notion d'addiction en économie : La théorie du choix rationnel à l'épreuve," Revue d'économie politique, Dalloz, vol. 121(5), pages 713-750.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Davide Fortin & Vincent Di Beo & Sophie Massin & Yann Bisiou & Patrizia Carrieri & Tangui Barré, 2022. "A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use," Post-Print hal-03702711, HAL.

    Cited by:

    1. Davide Fortin, 2023. "Light cannabis as a substitute for addictive substances: A cross-sectional analysis of survey data in France and Italy," French Stata Users' Group Meetings 2023 10, Stata Users Group.

  2. Sophie Massin & Maxence Miéra, 2020. "Measuring consumer surplus in the case of addiction: A re-examination of the rational benchmark algebra," Post-Print hal-03131254, HAL.

    Cited by:

    1. Maxence Miéra & Sophie Massin & Vincent Eroukmanoff, 2023. "The social value of gambling: surplus estimates by gambling types for France," Post-Print hal-03972103, HAL.

  3. Sophie Massin & Antoine Nebout & Bruno Ventelou, 2017. "Predicting medical practices using various risk attitude measures," Post-Print hal-01744600, HAL.

    Cited by:

    1. Jean-Baptiste Simon Combes & Alain Paraponaris & Yann Videau, 2019. "French GPs’ Willingness to Delegate Tasks: May Financial Incentives Balance Risk Aversion?," AMSE Working Papers 1910, Aix-Marseille School of Economics, France.
    2. Christian König-Kersting & Johannes Lohse & Anna Louisa Merkel, 2020. "Active and Passive Risk-Taking," Working Papers 2020-04, Faculty of Economics and Statistics, Universität Innsbruck.
    3. Murong Yang & Laurence S. J. Roope & James Buchanan & Arthur E. Attema & Philip M. Clarke & A. Sarah Walker & Sarah Wordsworth, 2022. "Eliciting risk preferences that predict risky health behavior: A comparison of two approaches," Health Economics, John Wiley & Sons, Ltd., vol. 31(5), pages 836-858, May.
    4. Emmanuel Kemel & Antoine Nebout & Bruno Ventelou, 2021. "To test or not to test? Risk attitudes and prescribing by French GPs," Working Papers hal-03330153, HAL.
    5. Lutter, Johanna I. & Szentes, Boglarka & Wacker, Margarethe E. & Winter, Joachim & Wichert, Sebastian & Peters, Annette & Holle, Rolf & Leidl, Reiner, 2019. "Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study," Munich Reprints in Economics 78227, University of Munich, Department of Economics.
    6. Méndez, Susan J. & Scott, Anthony & Zhang, Yuting, 2021. "Gender differences in physician decisions to adopt new prescription drugs," Social Science & Medicine, Elsevier, vol. 277(C).
    7. Antoine Nebout & Marie Cavillon & Bruno Ventelou, 2018. "Comparing GPs’ risk attitudes for their own health and for their patients’ : a troubling discrepancy?," Post-Print hal-02084925, HAL.

  4. Jean-Michel Costes & Sophie Massin & Jeanne Etiemble, 2015. "L’évaluation de l’impact socio-économique des jeux d’argent et de hasard," Post-Print hal-01241493, HAL.

    Cited by:

    1. Daniela Capitanucci & Roberta Smaniotto, 2016. "I danni collaterali del gioco d?azzardo. Riflessioni per l?agenda di ricerca," PRISMA Economia - Societ? - Lavoro, FrancoAngeli Editore, vol. 2016(3), pages 100-116.

  5. Sophie Massin & Bruno Ventelou & Antoine Nebout-Javal & Pierre Verger & Céline Pulcini, 2015. "Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination," Post-Print hal-01241634, HAL.

    Cited by:

    1. Sophie Massin & Antoine Nebout & Bruno Ventelou, 2017. "Predicting medical practices using various risk attitude measures," Post-Print hal-01744600, HAL.
    2. Alejandro Arrieta & Ariadna García-Prado & Paula González & Jose Luis Pinto-Prades, 2016. "Risk Attitudes in Medical Decisions for Others: An Experimental Approach," Working Papers 16.07, Universidad Pablo de Olavide, Department of Economics.
    3. Xie, Lei & Hou, Pengwen & Han, Hongshuai, 2021. "Implications of government subsidy on the vaccine product R&D when the buyer is risk averse," Transportation Research Part E: Logistics and Transportation Review, Elsevier, vol. 146(C).
    4. Eilermann, Kerstin & Halstenberg, Katrin & Kuntz, Ludwig & Martakis, Kyriakos & Roth, Bernhard & Wiesen, Daniel, 2019. "The Effect of Expert Feedback on Antibiotic Prescribing in Pediatrics: Experimental Evidence," HERO Online Working Paper Series 2020:1, University of Oslo, Health Economics Research Programme.
    5. Emmanuel Kemel & Antoine Nebout & Bruno Ventelou, 2021. "To test or not to test? Risk attitudes and prescribing by French GPs," Working Papers hal-03330153, HAL.
    6. Kerstin Eilermann & Katrin Halstenberg & Ludwig Kuntz & Kyriakos Martakis & Bernhard Roth & Daniel Wiesen, 2019. "The Effect of Expert Feedback on Antibiotic Prescribing in Pediatrics: Experimental Evidence," Medical Decision Making, , vol. 39(7), pages 781-795, October.
    7. Castro, M.F.; & Guccio, C.; & Romeo, D.;, 2022. "An assessment of physicians’ risk attitudes using laboratory and field data," Health, Econometrics and Data Group (HEDG) Working Papers 22/26, HEDG, c/o Department of Economics, University of York.
    8. Méndez, Susan J. & Scott, Anthony & Zhang, Yuting, 2021. "Gender differences in physician decisions to adopt new prescription drugs," Social Science & Medicine, Elsevier, vol. 277(C).
    9. Antoine Nebout & Marie Cavillon & Bruno Ventelou, 2018. "Comparing GPs’ risk attitudes for their own health and for their patients’ : a troubling discrepancy?," Post-Print hal-02084925, HAL.

  6. Jean-Michel Costes & Sophie Massin & Jeanne Etiemble, 2014. "Première évaluation de l'impact socio-économique des jeux d'argent et de hasard en France," Post-Print hal-01241482, HAL.

    Cited by:

    1. Luc Beal & Hugues Séraphin & Giuseppe Modica & Manuela Pilato & Marco Platania, 2019. "Analysing the Mediating Effect of Heritage Between Locals and Visitors: An Exploratory Study Using Mission Patrimoine as a Case Study," Sustainability, MDPI, vol. 11(11), pages 1-15, May.

  7. Sophie Massin & Alain Paraponaris & Marion Bernhard & Pierre Verger & Marie Cavillon & Fanny Mikol & Bruno Ventelou, 2014. "Les médecins généralistes face au paiement à la performance et à la coopération avec les infirmiers," Post-Print hal-01241473, HAL.

    Cited by:

    1. Jean-Baptiste Simon Combes & Alain Paraponaris & Yann Videau, 2019. "French GPs’ Willingness to Delegate Tasks: May Financial Incentives Balance Risk Aversion?," AMSE Working Papers 1910, Aix-Marseille School of Economics, France.
    2. Christophe Loussouarn & Carine Franc & Yann Videau & Julien Mousquès, 2019. "Coopérer plus pour travailler plus : évaluation de l’expérimentation d’infirmière de pratique avancée Asalée sur l’activité du médecin généraliste," Erudite Working Paper 2019-13, Erudite.
    3. Julie Gilles de la Londe & Anissa Afrite & Julien Mousquès, 2023. "How does the quality of care for type 2 diabetic patients benefit from GPs-nurses’ teamwork? A staggered difference-in-differences design based on a French pilot program," International Journal of Health Economics and Management, Springer, vol. 23(3), pages 433-466, September.

  8. Sophie Massin, 2012. "Is harm reduction profitable? An analytical framework for corporate social responsibility based on an epidemic model of addictive consumption," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) inserm-00835345, HAL.

    Cited by:

    1. Georges Brousse & Patrick Bendimerad & Ingrid De Chazeron & Pierre Michel Llorca & Pascal Perney & Maurice Dematteis, 2014. "Alcoholism Risk Reduction in France: A Modernised Approach Related to Alcohol Misuse Disorders," IJERPH, MDPI, vol. 11(11), pages 1-12, November.
    2. Miléna Spach & Antoine Pietri, 2018. "Is Heavy Drinking Always Profitable For Alcohol Industry? An Epidemic Framework For Alcohol Consumption [Le binge drinking est-il toujours profitable à l’industrie alcoolière ? Un modèle épidémique," Post-Print hal-02867917, HAL.
    3. Miléna Spach & Antoine Pietri, 2018. "Is Heavy Drinking Always Profitable For Alcohol Industry? An Epidemic Framework For Alcohol Consumption [Le binge drinking est-il toujours profitable à l’industrie alcoolière ? Un modèle épidémique," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-02867917, HAL.

  9. Sophie Massin, 2011. "La notion d'addiction en économie : la théorie du choix rationnel à l'épreuve," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) hal-00671266, HAL.

    Cited by:

    1. Kchirid, Mustapha & Tarbalouti, Essaid & Elgraa, Mohamed, 2013. "Le comportement du musulman en matière de crédit à intérêt face à la contrainte religieuse [The behavior of the Muslim regarding credit with interest in front of the religious constraint]," MPRA Paper 56171, University Library of Munich, Germany.

Articles

  1. Sophie Massin & Maxence Miéra, 2020. "Measuring consumer surplus in the case of addiction: A re-examination of the rational benchmark algebra," Economics Bulletin, AccessEcon, vol. 40(4), pages 3171-3181.
    See citations under working paper version above.
  2. Sophie Massin & Antoine Nebout & Bruno Ventelou, 2018. "Predicting medical practices using various risk attitude measures," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(6), pages 843-860, July.
    See citations under working paper version above.
  3. Massin, Sophie, 2012. "Is harm reduction profitable? An analytical framework for corporate social responsibility based on an epidemic model of addictive consumption," Social Science & Medicine, Elsevier, vol. 74(12), pages 1856-1863.
    See citations under working paper version above.
  4. Sophie Massin, 2011. "La notion d'addiction en économie : La théorie du choix rationnel à l'épreuve," Revue d'économie politique, Dalloz, vol. 121(5), pages 713-750.
    See citations under working paper version above.Sorry, no citations of articles recorded.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 5 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HPE: History and Philosophy of Economics (2) 2008-10-28 2008-11-25
  2. NEP-DCM: Discrete Choice Models (1) 2023-02-20
  3. NEP-EXP: Experimental Economics (1) 2023-02-20
  4. NEP-HEA: Health Economics (1) 2023-11-20
  5. NEP-MIC: Microeconomics (1) 2009-05-23
  6. NEP-UPT: Utility Models and Prospect Theory (1) 2008-11-25

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Sophie Massin should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.